It may be. Time will tell. Joe uses another company that scored a big deal as a comparison. That makes sense. Although, a pharma may have determined they see more potential in the other tech. But, AltuCell did land a modest yet lucrative milestone incentive deal with Generex to advance their tech. Success in a study will add value.